Eton Pharmaceuticals, Inc. (ETON) › Shareholders' EquityEton Pharmaceuticals, Inc. (ETON) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2017: -$6.87M2018: $26.30M2019: $10.55M2020: $17.63M2021: $17.63M2022: $13.08M2023: $15.48M2024: $24.43M2025: $26.15M$26.15M2017Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$26.15M+7.1%2024$24.43M+57.8%2023$15.48M+18.3%2022$13.08M-25.8%2021$17.63M+0.0%2020$17.63M+67.1%2019$10.55M-59.9%2018$26.30M+482.6%2017-$6.87M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share